BioCryst Pharmaceuticals gets grant for inhibitors of the complement system for disease treatment

Discover how BioCryst Pharmaceuticals' patent for complement system inhibitors offers groundbreaking treatment options for various diseases.

Related Posts

F. Hoffmann-La Roche sees highest patent filings and gr...

Nov 24, 2023

Prescription drug costs for NHS rise by 8% to £10.4bn i...

Jun 9, 2023

Suicide hotlines promise anonymity. Dozens of their web...

Jun 14, 2023